Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

 

Predictors for cause-specific and timing of deaths in patients with COVID-19: a cohort study in Taiwan

Yen et al., BMC Infectious Diseases, doi:10.1186/s12879-024-09654-w
Aug 2024  
  Post
  Facebook
Share
  Source   PDF  
Mortality -103% Improvement Relative Risk Dexamethasone  Yen et al.  EARLY TREATMENT Is early treatment with dexamethasone beneficial for COVID-19? Retrospective 2,196 patients in Taiwan (January - July 2022) Higher mortality with dexamethasone (p=0.0002) c19early.org Yen et al., BMC Infectious Diseases, Aug 2024 Favorsdexamethasone Favorscontrol 0 0.5 1 1.5 2+
Retrospective 2,196 COVID-19 patients in Taiwan (49% mild cases, 44% moderate, 7% severe) showing significantly higher mortality with dexamethasone.
Authors report that all infected patients were hospitalized at the time of the study in Taiwan.
Study covers molnupiravir and paxlovid.
risk of death, 103.0% higher, HR 2.03, p < 0.001, treatment 572, control 1,624, adjusted per study, multivariable, Cox proportional hazards.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Yen et al., 20 Aug 2024, retrospective, Taiwan, peer-reviewed, 6 authors, study period 1 January, 2022 - 31 July, 2022. Contact: dxd41@tpech.gov.tw.
This PaperMiscellaneousAll
Predictors for cause-specific and timing of deaths in patients with COVID-19: a cohort study in Taiwan
Yung-Feng Yen, Shang-Yih Chan, Yun-Ju Lai, Muh-Yong Yen, Chu-Chieh Chen, Mei-Ju Chen
doi:10.1186/s12879-024-09654-w
Background This cohort study determines the predictors for cause-specific and timing of deaths in patients with COVID-19 in Taiwan. Methods Patients with laboratory-confirmed COVID-19 admitted to Taipei City Hospital from January 1 to July 31, 2022, were recruited in this cohort. All patients were followed up until death, discharge from the hospital, or August 31, 2022. Early deaths within the first 2 weeks were recorded, and the cause of death was confirmed by the death certificate database of Taiwan. Predictors of cause-specific and timing of deaths of patients with COVID-19 were determined using multinomial Cox proportional hazards regression analysis. Results Of the 195 (8.0%) patients who died during hospitalization, 147 (84.0%) had COVID-19-specific deaths. Moreover, 54.9% of the deceased patients had early death. After controlling for other covariates, patients aged ≥ 65 years had a higher risk of COVID-19-specific, non-COVID-19-specific, early, and late deaths [adjusted hazards ratio (AHR): 3.85, 6.45, 3.33, and 6.57; 95% confidence interval (CI): 1. 91-7.78, 1.17-35.68, 1.51-7.36, and 2.18-19.76, respectively]. Fully vaccinated patients had a lower risk of COVID-19-specific (AHR: 0.68; 95% CI: 0.47-0.98) and early deaths (AHR: 0.54; 95% CI: 0.35-0.84), whereas comorbid patients with chronic obstructive pulmonary disease had a higher risk of non-COVID-19-specific deaths (AHR: 5.43; 95% CI: 1.73-17.03). Conclusions This study suggests that prioritizing COVID-19 vaccination and carefully monitoring comorbid patients during hospitalization can reduce the risk of COVID-19-specific and early deaths and non-COVID-19-specific mortalities, respectively.
Abbreviations Declarations Ethics approval and consent to participate This study was approved by the Institutional Review Board of Taipei City Hospital (no. TCHIRB-10904014-E). Formal consent is waived for this type of study. Consent for publication Not Applicable. Competing interests The authors declare no competing interests. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Berrino, Donzelli, Bellavite, Malatesta, COVID-19 vaccination and all-cause and non-COVID-19 mortality. A revaluation of a study carried out in an Italian Province, Epidemiologia e prevenzione
Bienvenu, Noonan, Wang, Peter, Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities, Cardiovasc Res
Chen, Cheuh, Chen, Kuo, Epidemiological characteristics of the three waves of COVID-19 epidemic in Taiwan during April 2022 to March 2023, J Formos Med Assoc
De Roquetaillade, Bredin, Lascarrou, Soumagne, Cojocaru et al., Timing and causes of death in severe COVID-19 patients, Crit Care
Finelli, Gupta, Petigara, Yu, Bauer et al., Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020, JAMA Netw Open
Gray, Navaratnam, Day, Wendon, Briggs, Changes in COVID-19 in-hospital mortality in hospitalised adults in England over the first seven months of the pandemic: an observational study using administrative data, Lancet Reg Health Eur
Hiscott, Alexandridi, Muscolini, Tassone, Palermo et al., The global impact of the coronavirus pandemic, Cytokine Growth Factor Rev
Hu, Guo, Zhou, Shi, Characteristics of SARS-CoV-2 and COVID-19, Nat Rev Microbiol
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Kabir, Ahmed, Chowdhury, Iqbal, Paulmurugan et al., Management of COVID-19: current status and future prospects, Microbes Infect
Lu, Lee, Chou, Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics, Int J Epidemiol
Meng, Lu, Guo, Liu, Yang et al., Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis, J Hematol Oncol
Mølhave, Agergaard, Wejse, Clinical management of COVID-19 patients -an update, Semin Nucl Med
Opal, Girard, Ely, The immunopathogenesis of sepsis in elderly patients, Clin Infect Dis
Peña, Rascón-Pacheco, Ascencio-Montiel, González-Figueroa, Fernández-Gárate et al., Hypertension, diabetes and obesity, major risk factors for death in patients with COVID-19 in Mexico, Arch Med Res
Rahmani, Shavaleh, Forouhi, Disfani, Kamandi et al., The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: a systematic review and meta-analysis, Front Public Health
Sadarangani, Marchant, Kollmann, Immunological mechanisms of vaccine-induced protection against COVID-19 in humans, Nat Rev Immunol
Sheng, Hsieh, Chang, Achievements of COVID-19 vaccination programs: Taiwanese perspective, J Formos Med Assoc
Smits, De Lang, Van Den Brand, Leijten, Van et al., Exacerbated innate host response to SARS-CoV in aged non-human primates, PLoS pathogens
Watson, Barnsley, Toor, Hogan, Winskill et al., Global impact of the first year of COVID-19 vaccination: a mathematical modelling study, Lancet Infect Dis
Wu, Mcgoogan, Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA
Yung, Li, Kehm, Cone, Parton et al., COVID-19-Specific Mortality among World Trade Center Health Registry Enrollees Who Resided in New York City, Int J Environ Res Public Health
Zheng, Shao, Chen, Zhang, Wang et al., Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis, Int J Infect Dis
DOI record: { "DOI": "10.1186/s12879-024-09654-w", "ISSN": [ "1471-2334" ], "URL": "http://dx.doi.org/10.1186/s12879-024-09654-w", "alternative-id": [ "9654" ], "article-number": "840", "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "18 October 2023" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "23 July 2024" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "20 August 2024" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Ethics approval and consent to participate", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "This study was approved by the Institutional Review Board of Taipei City Hospital (no. TCHIRB-10904014-E). Formal consent is waived for this type of study." }, { "group": { "label": "Consent for publication", "name": "EthicsHeading" }, "name": "Ethics", "order": 3, "value": "Not Applicable." }, { "group": { "label": "Competing interests", "name": "EthicsHeading" }, "name": "Ethics", "order": 4, "value": "The authors declare no competing interests." } ], "author": [ { "affiliation": [], "family": "Yen", "given": "Yung-Feng", "sequence": "first" }, { "affiliation": [], "family": "Chan", "given": "Shang-Yih", "sequence": "additional" }, { "affiliation": [], "family": "Lai", "given": "Yun-Ju", "sequence": "additional" }, { "affiliation": [], "family": "Yen", "given": "Muh-Yong", "sequence": "additional" }, { "affiliation": [], "family": "Chen", "given": "Chu-Chieh", "sequence": "additional" }, { "affiliation": [], "family": "Chen", "given": "Mei-Ju", "sequence": "additional" } ], "container-title": "BMC Infectious Diseases", "container-title-short": "BMC Infect Dis", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2024, 8, 20 ] ], "date-time": "2024-08-20T06:02:39Z", "timestamp": 1724133759000 }, "deposited": { "date-parts": [ [ 2024, 8, 20 ] ], "date-time": "2024-08-20T06:02:44Z", "timestamp": 1724133764000 }, "funder": [ { "DOI": "10.13039/501100015835", "award": [ "No. 11101-62-042; No. 11201-62-023" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100015835", "id-type": "DOI" } ], "name": "Department of Health, Taipei City Government" } ], "indexed": { "date-parts": [ [ 2024, 8, 28 ] ], "date-time": "2024-08-28T14:10:53Z", "timestamp": 1724854253046 }, "is-referenced-by-count": 0, "issue": "1", "issued": { "date-parts": [ [ 2024, 8, 20 ] ] }, "journal-issue": { "issue": "1", "published-online": { "date-parts": [ [ 2024, 12 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 8, 20 ] ], "date-time": "2024-08-20T00:00:00Z", "timestamp": 1724112000000 } }, { "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 8, 20 ] ], "date-time": "2024-08-20T00:00:00Z", "timestamp": 1724112000000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1186/s12879-024-09654-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1186/s12879-024-09654-w/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1186/s12879-024-09654-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1186", "published": { "date-parts": [ [ 2024, 8, 20 ] ] }, "published-online": { "date-parts": [ [ 2024, 8, 20 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1016/j.cytogfr.2020.05.010", "author": "J Hiscott", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Cytokine Growth Factor Rev", "key": "9654_CR1", "unstructured": "Hiscott J, Alexandridi M, Muscolini M, Tassone E, Palermo E, Soultsioti M, Zevini A. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020;53:1–9.", "volume": "53", "year": "2020" }, { "key": "9654_CR2", "unstructured": "World Health Organization: Coronavirus disease (COVID-19) Pandemic. https://www.who.int/publications/m/item/covid-19-weekly-epidemiological-update---21-december-2022. Accessed 16 July 2023." }, { "DOI": "10.1093/cvr/cvaa284", "author": "LA Bienvenu", "doi-asserted-by": "publisher", "first-page": "2197", "issue": "14", "journal-title": "Cardiovasc Res", "key": "9654_CR3", "unstructured": "Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020;116(14):2197–206.", "volume": "116", "year": "2020" }, { "DOI": "10.1016/j.arcmed.2020.12.002", "author": "JE Peña", "doi-asserted-by": "publisher", "first-page": "443", "issue": "4", "journal-title": "Arch Med Res", "key": "9654_CR4", "unstructured": "Peña JE, Rascón-Pacheco RA, Ascencio-Montiel IJ, González-Figueroa E, Fernández-Gárate JE, Medina-Gómez OS, Borja-Bustamante P, Santillán-Oropeza JA, Borja-Aburto VH. Hypertension, diabetes and obesity, major risk factors for death in patients with COVID-19 in Mexico. Arch Med Res. 2021;52(4):443–9.", "volume": "52", "year": "2021" }, { "DOI": "10.1186/s13045-020-00907-0", "author": "Y Meng", "doi-asserted-by": "publisher", "first-page": "75", "issue": "1", "journal-title": "J Hematol Oncol", "key": "9654_CR5", "unstructured": "Meng Y, Lu W, Guo E, Liu J, Yang B, Wu P, Lin S, Peng T, Fu Y, Li F, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020;13(1):75.", "volume": "13", "year": "2020" }, { "DOI": "10.3390/ijerph192114348", "author": "J Yung", "doi-asserted-by": "publisher", "first-page": "14348", "issue": "21", "journal-title": "Int J Environ Res Public Health", "key": "9654_CR6", "unstructured": "Yung J, Li J, Kehm RD, Cone JE, Parton H, Huynh M, Farfel MR. COVID-19-Specific Mortality among World Trade Center Health Registry Enrollees Who Resided in New York City. Int J Environ Res Public Health. 2022;19(21):14348.", "volume": "19", "year": "2022" }, { "DOI": "10.1001/jama.2020.2648", "author": "Z Wu", "doi-asserted-by": "publisher", "first-page": "1239", "issue": "13", "journal-title": "JAMA", "key": "9654_CR7", "unstructured": "Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.", "volume": "323", "year": "2020" }, { "DOI": "10.1038/s41579-020-00459-7", "author": "B Hu", "doi-asserted-by": "publisher", "first-page": "141", "issue": "3", "journal-title": "Nat Rev Microbiol", "key": "9654_CR8", "unstructured": "Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–54.", "volume": "19", "year": "2021" }, { "DOI": "10.1001/jamanetworkopen.2021.6556", "author": "L Finelli", "doi-asserted-by": "publisher", "first-page": "e216556", "issue": "4", "journal-title": "JAMA Netw Open", "key": "9654_CR9", "unstructured": "Finelli L, Gupta V, Petigara T, Yu K, Bauer KA, Puzniak LA. Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020. JAMA Netw Open. 2021;4(4):e216556.", "volume": "4", "year": "2021" }, { "DOI": "10.1016/S0140-6736(20)30183-5", "author": "C Huang", "doi-asserted-by": "publisher", "first-page": "497", "issue": "10223", "journal-title": "Lancet (London, England)", "key": "9654_CR10", "unstructured": "Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395(10223):497–506.", "volume": "395", "year": "2020" }, { "DOI": "10.1186/s13054-021-03639-w", "author": "C de Roquetaillade", "doi-asserted-by": "publisher", "first-page": "224", "issue": "1", "journal-title": "Crit Care (London, England)", "key": "9654_CR11", "unstructured": "de Roquetaillade C, Bredin S, Lascarrou JB, Soumagne T, Cojocaru M, Chousterman BG, Leclerc M, Gouhier A, Piton G, Pène F, et al. Timing and causes of death in severe COVID-19 patients. Crit Care (London, England). 2021;25(1):224.", "volume": "25", "year": "2021" }, { "key": "9654_CR12", "unstructured": "Taiwan Centers for Disease Control and Prevention. [Surveillance of COVID-19]. https://www.cdc.gov.tw/En. Accessed 29 Apr 2020." }, { "DOI": "10.1093/ije/29.2.336", "author": "TH Lu", "doi-asserted-by": "publisher", "first-page": "336", "issue": "2", "journal-title": "Int J Epidemiol", "key": "9654_CR13", "unstructured": "Lu TH, Lee MC, Chou MC. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol. 2000;29(2):336–43.", "volume": "29", "year": "2000" }, { "key": "9654_CR14", "unstructured": "Taiwan Centers for Disease Control and Prevention: Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). https://www.cdc.gov.tw/Category/Page/xCSwc5oznwcqunujPc-qmQ. Accessed 21 Mar 2023." }, { "DOI": "10.1016/j.lanepe.2021.100104", "author": "WK Gray", "doi-asserted-by": "publisher", "first-page": "100104", "journal-title": "Lancet Reg Health Eur", "key": "9654_CR15", "unstructured": "Gray WK, Navaratnam AV, Day J, Wendon J, Briggs TWR. Changes in COVID-19 in-hospital mortality in hospitalised adults in England over the first seven months of the pandemic: an observational study using administrative data. Lancet Reg Health Eur. 2021;5:100104.", "volume": "5", "year": "2021" }, { "DOI": "10.3389/fpubh.2022.873596", "author": "K Rahmani", "doi-asserted-by": "publisher", "first-page": "873596", "journal-title": "Front Public Health", "key": "9654_CR16", "unstructured": "Rahmani K, Shavaleh R, Forouhi M, Disfani HF, Kamandi M, Oskooi RK, Foogerdi M, Soltani M, Rahchamani M, Mohaddespour M, et al. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: a systematic review and meta-analysis. Front Public Health. 2022;10:873596.", "volume": "10", "year": "2022" }, { "DOI": "10.1053/j.semnuclmed.2021.06.004", "author": "M Mølhave", "doi-asserted-by": "publisher", "first-page": "4", "issue": "1", "journal-title": "Semin Nucl Med", "key": "9654_CR17", "unstructured": "Mølhave M, Agergaard J, Wejse C. Clinical management of COVID-19 patients - an update. Semin Nucl Med. 2022;52(1):4–10.", "volume": "52", "year": "2022" }, { "DOI": "10.1016/j.micinf.2021.104832", "author": "MA Kabir", "doi-asserted-by": "publisher", "first-page": "104832", "issue": "4–5", "journal-title": "Microbes Infect", "key": "9654_CR18", "unstructured": "Kabir MA, Ahmed R, Chowdhury R, Iqbal SMA, Paulmurugan R, Demirci U, Asghar W. Management of COVID-19: current status and future prospects. Microbes Infect. 2021;23(4–5):104832.", "volume": "23", "year": "2021" }, { "DOI": "10.1086/432007", "author": "SM Opal", "doi-asserted-by": "publisher", "first-page": "S504", "issue": "Suppl 7", "journal-title": "Clin Infect Dis", "key": "9654_CR19", "unstructured": "Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Suppl 7):S504-512.", "volume": "41", "year": "2005" }, { "DOI": "10.1371/journal.ppat.1000756", "author": "SL Smits", "doi-asserted-by": "publisher", "first-page": "e1000756", "issue": "2", "journal-title": "PLoS pathogens", "key": "9654_CR20", "unstructured": "Smits SL, de Lang A, van den Brand JM, Leijten LM, van IWF, Eijkemans MJ, van Amerongen G, Kuiken T, Andeweg AC, Osterhaus AD, et al. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS pathogens. 2010;6(2):e1000756.", "volume": "6", "year": "2010" }, { "DOI": "10.1016/j.jfma.2023.04.017", "author": "WH Sheng", "doi-asserted-by": "publisher", "first-page": "S70", "issue": "Suppl 1", "journal-title": "J Formos Med Assoc", "key": "9654_CR21", "unstructured": "Sheng WH, Hsieh SM, Chang SC. Achievements of COVID-19 vaccination programs: Taiwanese perspective. J Formos Med Assoc. 2024;123(Suppl 1):S70-s76.", "volume": "123", "year": "2024" }, { "DOI": "10.1016/S1473-3099(22)00320-6", "author": "OJ Watson", "doi-asserted-by": "publisher", "first-page": "1293", "issue": "9", "journal-title": "Lancet Infect Dis", "key": "9654_CR22", "unstructured": "Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293–302.", "volume": "22", "year": "2022" }, { "DOI": "10.1016/j.ijid.2021.11.009", "author": "C Zheng", "doi-asserted-by": "publisher", "first-page": "252", "journal-title": "Int J Infect Dis", "key": "9654_CR23", "unstructured": "Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252–60.", "volume": "114", "year": "2022" }, { "DOI": "10.1038/s41577-021-00578-z", "author": "M Sadarangani", "doi-asserted-by": "publisher", "first-page": "475", "issue": "8", "journal-title": "Nat Rev Immunol", "key": "9654_CR24", "unstructured": "Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol. 2021;21(8):475–84.", "volume": "21", "year": "2021" }, { "author": "F Berrino", "first-page": "374", "issue": "6", "journal-title": "Epidemiologia e prevenzione", "key": "9654_CR25", "unstructured": "Berrino F, Donzelli A, Bellavite P, Malatesta G. COVID-19 vaccination and all-cause and non-COVID-19 mortality. A revaluation of a study carried out in an Italian Province. Epidemiologia e prevenzione. 2023;47(6):374–8.", "volume": "47", "year": "2023" }, { "DOI": "10.1016/j.jfma.2023.05.027", "author": "YH Chen", "doi-asserted-by": "publisher", "first-page": "1174", "issue": "11", "journal-title": "J Formos Med Assoc", "key": "9654_CR26", "unstructured": "Chen YH, Cheuh YN, Chen CM, Kuo HW. Epidemiological characteristics of the three waves of COVID-19 epidemic in Taiwan during April 2022 to March 2023. J Formos Med Assoc. 2023;122(11):1174–82.", "volume": "122", "year": "2023" } ], "reference-count": 26, "references-count": 26, "relation": {}, "resource": { "primary": { "URL": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09654-w" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Predictors for cause-specific and timing of deaths in patients with COVID-19: a cohort study in Taiwan", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "24" }
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit